hotspot -WSS

hotspot

author：knowledge 2025-10-06 07:54:56 - browse：899

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： The pink breast cancer awareness ribbon needs a redesign

WSS

Emergency medicine has repudiated 'excited delirium.' Now what?

Readout Newsletter: Merck, J&J, and long Covid

WHO may add ‘noma' to its list of neglected tropical diseases

Chimpanzees, like humans and whales, get menopause: Study

EU regulator recommends expanding Mounjaro approval to obesity

Chimpanzees, like humans and whales, get menopause: Study

knowledge

hotspot

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Diversifying clinical trials isn't enough to close racial gaps: study

Medicare details structure of new drug price negotiation program

Why Sanofi got shellacked over its spinoff

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Test for long Covid? Researchers find new clue in blood samples

Guidelines to prevent youth baseball injuries need more muscle

The pink breast cancer awareness ribbon needs a redesign

Dobbs anniversary: the lost opportunity of abortion as health care

The FDA weighs the risks of candy

hotspot

How digital therapeutics firms are pivoting after Pear's bankruptcy

Research misconduct: Proposed new rules face resistance

The pink breast cancer awareness ribbon needs a redesign

How digital therapeutics firms are pivoting after Pear's bankruptcy

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

First Opinion Podcast: How to protect health care in times of war

Wikipedia

explore

hotspot

Wikipedia